Results 81 to 90 of about 64,748,975 (303)

Office of Protection and Advocacy for Persons with Disabilities [web site] [Harvested on 2011: May 24]

open access: yes, 2011
Updated irregularly; Began in 2002?; Title from home page (publisher's Web site, viewed May 23, 2011).; At head of title: State of Connecticut.; Harvested from the web on 5/24/11Official website of the Connecticut Office of Protection and Advocacy for ...

core  

Association Between Motor Pathway Damage and Motor Deficit in Upper and Lower Limb in People With MS

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Corticospinal tract damage is common in people with MS, but the degree of clinical symptoms varies. We hypothesize that corticospinal tract lesions are more extensive and severe in people with MS with motor impairments in both upper and lower limbs.
Mathilde Liffran   +13 more
wiley   +1 more source

Office of Protection and Advocacy for Persons with Disabilities [web site] [Harvested on 2013: Oct. 28]

open access: yes, 2013
Updated irregularly; Began in 2002?; Title from home page (publisher's Web site, viewed May 23, 2011).; At head of title: State of Connecticut.; Harvested from the web on 10/28/13Official website of the Connecticut Office of Protection and Advocacy for ...

core  

Spatial and Volumetric Characteristics of Glioblastoma: Associations With Clinical Presentation and Survival

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective We aim to comprehensively analyze how regional tumor and edema characteristics are associated with clinical presentations and survival outcomes in a large cohort of glioblastoma patients. Methods Patients with IDH‐wildtype glioblastoma who received brain MRI from 2010 to 2023 were included.
Daniel J. Zhou   +16 more
wiley   +1 more source

Clinical Impact of NOTCH3 Variant Location After First Stroke in CADASIL

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Despite its monogenic origin, Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy exhibits marked variability in clinical expression and severity. Variants in the NOTCH3 gene, within epidermal growth factor‐like repeat domains 1–6 or 7–34, are known to influence disease onset, but their impact ...
Léa Aguilhon   +5 more
wiley   +1 more source

Development of Wearable Sheet-Type Shear Force Sensor and Measurement System that is Insusceptible to Temperature and Pressure

open access: yesSensors, 2017
A sheet-type shear force sensor and a measurement system for the sensor were developed. The sensor has an original structure where a liquid electrolyte is filled in a space composed of two electrode-patterned polymer films and an elastic rubber ring ...
Shigeru Toyama   +7 more
doaj   +1 more source

Evaluation of Digital Technologies for Home‐Based Assessment in People With Amyotrophic Lateral Sclerosis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Digital technologies hold promise for transforming healthcare by enhancing personalized treatments and offer valuable opportunities to improve patient care. Here, we evaluated several novel, self‐administered, home‐based, digital endpoints for their association with corresponding conventional standard clinical measures (primary) in ...
Arne Mueller   +14 more
wiley   +1 more source

Office of Protection and Advocacy for Persons with Disabilities [web site] [Harvested on 2014: Oct. 17]

open access: yes, 2014
Updated irregularly; Began in 2002?; Title from home page (publisher's Web site, viewed May 23, 2011).; At head of title: State of Connecticut.; Harvested from the web on 10/17/14Official website of the Connecticut Office of Protection and Advocacy for ...

core  

Unraveling 4‐Phenylbutyrate's Therapeutic Role in SLC6A1 Disorders: Pharmacochaperoning Over HDAC Inhibition

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Variants in SLC6A1, encoding the GABA transporter 1 (GAT‐1), cause epilepsy, autism spectrum disorder, and developmental delay via loss of GABA uptake, impaired trafficking, and ER retention. We previously found that 4‐Phenylbutyrate (PBA), an FDA‐approved drug, restores GABA uptake and reduces seizures in SLC6A1‐related disorders ...
Melissa B. DeLeeuw   +5 more
wiley   +1 more source

Disability resource directory for people with disabilities. [Harvested on 2012: Nov. 5]

open access: yes, 2006
Rev. Oct. 2006.; Cover title.; "Ver. JM.2.00"--P. [4] of cover.; Imprint from p. 4 of cover.; Previously issued as: Disability resources in Connecticut / compiled by the State Office of Protection and Advocacy for Persons with Disabilities. Hartford, CT :

core   +1 more source

Home - About - Disclaimer - Privacy